MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$1,157M
Depreciation and
amortization
$1,011M
Proceeds from long-term
borrowings
$7,569M
Stock-based compensation
expense
$76M
Accounts payable
$73M
Non-cash lease expense
$72M
Unrealized foreign
exchange loss (gain), net
-$68M
Amortization of deferred
financing costs
$59M
Loss on
extinguishment of debt
-$58M
Credit losses
$54M
Other non-cash
adjustments
-$13M
Proceeds from issuance of
class a common stock in...
$7,048M
Proceeds from lines of
credit
$179M
Net cash provided by
operating activities
$1,744M
Net cash provided by
(used in) financing...
$399M
Effect of exchange rate
changes on cash and cash...
$23M
Canceled cashflow
$897M
Canceled cashflow
$14,397M
Net change in cash
and cash...
$1,692M
Canceled cashflow
$474M
Trade accounts
receivable
$355M
Inventories
$264M
Other assets
$126M
Accrued expenses and
other current...
-$92M
Embedded derivative on
debt
$41M
Other liabilities
-$19M
Acquisitions of businesses,
net of cash acquired
-$6M
Repayment for long-term
borrowings
$11,661M
Purchase of class a common
stock and redemptions...
$1,970M
Distributions to partners
$518M
Repayments under lines of
credit
$179M
Payment for offering
costs
$36M
Payment towards class b
unit repurchases
$33M
Net cash used in
investing activities
-$474M
Canceled cashflow
$6M
Purchases of property and
equipment, net
$447M
Cash paid for asset
acquisitions
$33M
Back
Back
Cash Flow
source: myfinsight.com
Medline Inc. (MDLN)
Medline Inc. (MDLN)